Correlation Between Orchard Therapeutics and Salarius Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Orchard Therapeutics and Salarius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orchard Therapeutics and Salarius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orchard Therapeutics PLC and Salarius Pharmaceuticals, you can compare the effects of market volatilities on Orchard Therapeutics and Salarius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orchard Therapeutics with a short position of Salarius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orchard Therapeutics and Salarius Pharmaceuticals.
Diversification Opportunities for Orchard Therapeutics and Salarius Pharmaceuticals
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Orchard and Salarius is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Orchard Therapeutics PLC and Salarius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Salarius Pharmaceuticals and Orchard Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orchard Therapeutics PLC are associated (or correlated) with Salarius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Salarius Pharmaceuticals has no effect on the direction of Orchard Therapeutics i.e., Orchard Therapeutics and Salarius Pharmaceuticals go up and down completely randomly.
Pair Corralation between Orchard Therapeutics and Salarius Pharmaceuticals
Given the investment horizon of 90 days Orchard Therapeutics PLC is expected to generate 0.33 times more return on investment than Salarius Pharmaceuticals. However, Orchard Therapeutics PLC is 3.07 times less risky than Salarius Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Salarius Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest 497.00 in Orchard Therapeutics PLC on August 31, 2024 and sell it today you would earn a total of 30.00 from holding Orchard Therapeutics PLC or generate 6.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 8.56% |
| Values | Daily Returns |
Orchard Therapeutics PLC vs. Salarius Pharmaceuticals
Performance |
| Timeline |
| Orchard Therapeutics PLC |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Salarius Pharmaceuticals |
Orchard Therapeutics and Salarius Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Orchard Therapeutics and Salarius Pharmaceuticals
The main advantage of trading using opposite Orchard Therapeutics and Salarius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orchard Therapeutics position performs unexpectedly, Salarius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salarius Pharmaceuticals will offset losses from the drop in Salarius Pharmaceuticals' long position.| Orchard Therapeutics vs. X4 Pharmaceuticals | Orchard Therapeutics vs. Terns Pharmaceuticals | Orchard Therapeutics vs. Day One Biopharmaceuticals | Orchard Therapeutics vs. PDS Biotechnology Corp |
| Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Histogen | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. Aileron Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |